Renal Cancer - Results from #3420

Baseline perfusion CT parameters as potential biomarkers in predicting long-term prognosis of localized clear cell renal cell carcinoma. August 12, 2019

Comparison of survival benefits of nephron-sparing intervention or active surveillance for patients with localized renal masses: a systematic review and meta-analysis. August 12, 2019

DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts. August 9, 2019

Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. August 9, 2019

Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study. August 9, 2019

Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights. August 8, 2019

Prognostic value of pretreatment neutrophil count in metastatic renal cell carcinoma: a systematic review and meta-analysis. August 8, 2019

miR-142-3p as a novel biomarker for predicting poor prognosis in renal cell carcinoma patients after surgery. August 8, 2019

Urine Metabolomics for Renal Cell Carcinoma (RCC) Prediction: Tryptophan Metabolism as an Important Pathway in RCC. August 7, 2019

Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database. August 7, 2019

The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma. August 7, 2019

Severe Vaginal Bleeding in a Case of Renal Cell Carcinoma. August 6, 2019

Glutathione Metabolism in Renal Cell Carcinoma Progression and Implications for Therapies. August 6, 2019

Sequencing and Combination of Systemic Therapy in Metastatic Renal Cell Carcinoma. August 6, 2019

Patient-derived xenograft models to optimize kidney cancer therapies. August 5, 2019

Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia. August 5, 2019

Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: A SEER-based analysis. August 5, 2019

Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1. August 2, 2019

Urinary Metabolomics Validates Metabolic Differentiation Between Renal Cell Carcinoma Stages and Reveals a Unique Metabolic Profile for Oncocytomas. August 2, 2019

Influence of lymph node dissection in patients undergoing radical nephrectomy for non-metastatic renal cell carcinoma: a systematic review and meta-analysis. August 2, 2019

Page 172 of 458